Freudenberg Medical announces the appointment of Dr. Max Gisbert Kley as the new CEO

CARPINTERIA, California – August 1, 2016 –Freudenberg Medical, a global developer and manufacturer of medical devices, components, and minimally invasive solutions for the medical device and pharmaceutical industry, announces the appointment of Dr. Max Gisbert Kley as the new CEO of Freudenberg Medical.

Dr. Kley has worked for the Freudenberg Group since 2000, initially leading the Mergers & Acquisitions department. In 2005 he served as CFO North America for Freudenberg Household Products, then in 2008 returned to Germany to manage another Freudenberg business, Burgmann Automotive. In 2012 he joined the management board of Freudenberg Medical as President of Europe and Business Development and since 2015 he has led the global Specialty Components division of Freudenberg Medical.

“Freudenberg Medical is ideally positioned as a leading global partner to the medical device and pharmaceutical industry,” said Dr. Kley. “We will continue to execute on our successful growth strategy by serving our customers with an unrivalled range of innovative products and services”.

Dr. Kley’s appointment is effective August 1, 2016.

For more information visit

# #

About Freudenberg Medical
Freudenberg Medical is a global partner for the design, development and manufacture of innovative medical device technologies. With 11 manufacturing operations and more than 1,500 associates worldwide, Freudenberg Medical offers a wide range of capabilities from high precision silicone and thermoplastic components and tubing to coating technology, finished devices, and solutions for minimally invasive and catheter-based devices.